Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine during donor hepatectomy for liver transplantation
PACTR201909557694667Phase 4Completed
- Sponsor
- National Liver Institute
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine (2 arms), sponsored by National Liver Institute. Primary endpoints: Hepatic parenchymal protection assessed by laboratory parameters and Serum ICAM-1 level. Started Jan 2015; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on PACTR201909557694667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201909557694667.